1 Department of Gastroenterology, School of Medicine, University Hospital Merkur, University of Zagreb, Zagreb, Croatia.
2 Center of Excellence in Reproductive and Regenerative Medicine, School of Medicine, Zagreb, Croatia.
Stem Cells Dev. 2019 Jun 1;28(11):717-733. doi: 10.1089/scd.2018.0194. Epub 2019 Mar 11.
The spin-trap free radical scavenger -tert-butyl-α-phenylnitron (PBN) ameliorated effects of several teratogens involving reactive oxygen species (ROS). We investigated for the first time whether PBN could ameliorate teratogenesis induced by a DNA hypomethylating hematological therapeutic 5-azacytidine (5azaC). At days 12 and 13 of gestation, Fisher rat dams were pretreated by an i.v. injection of PBN (40 mg/kg) and 1 h later by an i.p. injection of 5azaC (5mg/kg). Development was analyzed at gestation day 15 in embryos and day 20 in fetuses. PBN alone did not significantly affect development. PBN pretreatment restored survival of 5azaC-treated dams' embryos to the control level, restored weight of embryos and partially of fetuses, and partially restored crown-rump lengths. PBN pretreatment converted limb adactyly to less severe oligodactyly. PBN pretreatment restored global DNA methylation level in the limb buds to the control level. Cell proliferation in limb buds of all 5azaC-treated dams remained significantly lower than in controls. In the embryonic liver, PBN pretreatment normalized proliferation diminished significantly by 5azaC; whereas in embryonic vertebral cartilage, proliferation of all 5azaC-treated dams was significantly higher than in PBN-treated dams or controls. Apoptotic indices significantly enhanced by 5azaC in liver and cartilage were not influenced by PBN pretreatment. However, PBN significantly diminished ROS or reactive nitrogen species markers nitrotyrosine and 8-hydroxy-2'deoxyguanosine elevated by 5azaC in embryonic tissues, and, therefore, activity of this DNA hypomethylating agent was associated to the activation of free radicals. That pretreatment with PBN enhanced proliferation in the liver and not in immature tissue is interesting for the treatment of 5azaC-induced hepatotoxicity and liver regeneration.
自旋捕获自由基清除剂 -叔丁基-α-苯硝酮(PBN)可改善涉及活性氧(ROS)的几种致畸剂的作用。我们首次研究了 PBN 是否可以改善 DNA 低甲基化血液治疗药物 5-氮杂胞苷(5azaC)诱导的致畸作用。在妊娠第 12 和 13 天,Fisher 大鼠母体通过静脉内注射 PBN(40mg/kg)预处理,并在 1 小时后通过腹腔内注射 5azaC(5mg/kg)。在胚胎第 15 天和胎儿第 20 天分析发育情况。PBN 单独使用不会显著影响发育。PBN 预处理将 5azaC 处理的母体胚胎的存活率恢复到对照水平,恢复胚胎和部分胎儿的体重,并部分恢复头臂长度。PBN 预处理将肢体缺指转化为较轻的多指畸形。PBN 预处理将肢体芽的整体 DNA 甲基化水平恢复到对照水平。所有 5azaC 处理的母体胚胎的细胞增殖仍明显低于对照组。在胚胎肝脏中,PBN 预处理使 5azaC 显著减少的增殖正常化;然而,在胚胎脊椎软骨中,所有 5azaC 处理的母体的增殖明显高于 PBN 处理的母体或对照组。5azaC 显著增强的凋亡指数在肝脏和软骨中不受 PBN 预处理的影响。然而,PBN 显著减少了由 5azaC 升高的 ROS 或活性氮物质标记物硝基酪氨酸和 8-羟基-2'-脱氧鸟苷,因此该 DNA 低甲基化剂的活性与自由基的激活有关。PBN 预处理增强了肝脏中的增殖而不是未成熟组织中的增殖,这对于治疗 5azaC 诱导的肝毒性和肝脏再生是有趣的。